Publications


C. DIFFICILE  |  FMT SAFETY & ACCESS  |  STOOL DONORS  |  LIVER DISEASE 

INFLAMMATORY BOWEL DISEASE (INCL. UC & CROHN'S)   |  OBESITY  |  & MORE

Some of these papers and abstracts are hosted behind their publication’s paywall - we’re sorry we can’t provide full access! Please email science@openbiome.org with any specific questions.

C.Difficile

2019

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose Allegretti, J., Fischer, M., Sagi, S., Bohm, M., Fadda, H., & Ranmal, S. et al. (2018). Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose. Digestive Diseases And Sciences, 64(6), 1672-1678. doi:10.1007/s10620-018-5396-6

Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis? Allegretti, J., Kao, D., Phelps, E., Roach, B., Smith, J., & Ganapini, V. et al. (2019). Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?. Digestive Diseases And Sciences. doi:10.1007/s10620-018-5450-4

Bezlotoxumab use as adjunctive therapy with the third fecal microbiota transplant in refractory recurrent Clostridium difficilecolitis; a case report and concise literature review Kaako, A., Al-Amer, M., & Abdeen, Y. (2019). Bezlotoxumab use as adjunctive therapy with the third fecal microbiota transplant in refractory recurrent Clostridium difficile colitis; a case report and concise literature review. Anaerobe55, 112-116. doi:10.1016/j.anaerobe.2018.11.010

Patients Eligible for Trials of Microbe-based Therapeutics do not Represent the Population With Recurrent Clostridioides difficile Infection Kelly, C., Fischer, M., Grinspan, A., & Allegretti, J. (2019). Patients Eligible for Trials of Microbe-based Therapeutics do not Represent the Population With Recurrent Clostridioides difficile Infection. Clinical Gastroenterology And Hepatology. doi:10.1016/j.cgh.2019.06.034

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis Shin, J., Chaplin, A., Hays, R., Kolling, G., Vance, S., & Guerrant, R. et al. (2019). Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis. Journal Of Clinical Medicine8(7), 1036. doi:10.3390/jcm8071036

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients Tixier, E., Verheyen, E., Ungaro, R., & Grinspan, A. (2019). Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients. Alimentary Pharmacology & Therapeutics. doi:10.1111/apt.15526

2018 

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose Allegretti, J. R., Fischer, M., Sashidar V. S., Bohm, M. E., Fadda, H. M., Ranmal, S. R., Budree, S., Basit, A. W., Glettif, D. L., de la Serna, E. L., Gentile, A., Gerardin, Y., Timberlake, S. T., Sadovsky, R., Smith, M., Kassam, Z. (2018). Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-018-5396-6.

The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection
Allegretti, J. R., Kassam, Z., Osman, M., Budree, S., Fischer, M., & Kelly, C. R. (2018). The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointestinal endoscopy87(1), 18-29.

Frail Heart, Friable Colon: A Case Report of Fecal Microbiota Transplant for Refractory Clostridium difficile Infection in a Patient with Recent Trans-Catheter Aortic Valve Replacement Bhanvadia, A. (2018) Frail Heart, Friable Colon: A Case Report of Fecal Microbiota Transplant for Refractory Clostridium difficile Infection in a Patient with Recent Trans-Catheter Aortic Valve Replacement. J Inflam Bowel Dis & Discord 3(1): 124.

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection Brown, J. R. M., Flemer, B., Joyce, S. A., Zulquernain, A., Sheehan, D., Shanahan, F., & O’Toole, P. W. (2018). Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. BMC Gastroenterology, 18(1), 131.

Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection? Budree, S., Osman, M., Panchal, P., Shu, E., Carrellas, M., Kassam, Z., & Allegretti, J. (2018, November). 618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?. Open Forum Infectious Diseases (Vol. 5, No. suppl_1, pp. S225-S226). US: Oxford University Press.

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience Cheng, Y. W., Phelps E., Ganapini V., Khan N., Ouyang, F., Xu H., … & Fischer M. (2018) Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. American Journal of Transplantation, 10.1111/ajt.15058.

2017

Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment. 
Allegretti, J. R., Allegretti, A. S., Phelps, E., Xu, H., Kassam, Z., & Fischer, M. (2017). Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment. Clinical Microbiology and Infection

Donor stool processing time: the effect on the intestinal microbiome and clinical outcomes of fecal microbiota transplantation in Clostridium difficile Infection
Budree, S., Elliott, R. J., Rao, S., Njenga, M., Ladha, A., Allegretti, J. R., ... & Kassam, Z. (2017). Donor Stool Processing Time: The Effect on the Intestinal Microbiome and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S1006.

The association of donor stool consistency by Bristol stool scale on microbial profile and clinical outcomes of fecal microbiota transplantation in Clostridium difficile infection
Budree, S., Rao, S., Allegretti, J. R., Fischer, M., Kelly, C. R., Smith, M., ... & Kassam, Z. (2017). The Association of Donor Stool Consistency by Bristol Stool Scale on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630.

The association of stool donor diet on microbial profile and clinical outcomes of fecal microbiota transplantation in clostridium difficile infection
Budree, S., Tu, E., Leith, T., Allegretti, J. R., Rao, S., Day, R., ... & Osman, M. (2017). The Association of Stool Donor Diet on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630-S631.

Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors
Budree, S., Wong, W. F., Tu, E., Rao, S., Allegretti, J. R., Fischer, M., ... & Kassam, Z. (2017). Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors. Gastroenterology152(5), S349.

Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease
Fischer, M., Bittar, M., Papa, E., Kassam, Z., & Smith, M. (2017). Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut microbes, 8(3), 205-207.

Should we recommend anti-Clostridium difficile antibiotic or probiotic prophylaxis? Risk of Clostridium difficile infection with systemic antimicrobial therapy following successful fecal microbiota transplant
Fischer, M., Kao, D. H., Phelps, E. L., Smith, J. D., Roach, B., Kassam, Z., ... & Allegretti, J. R. (2017). Should we Recommend Anti-Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant. Gastroenterology152(5), S1005.

A Surgical Clostridium-associated Risk of Death Score Predicts Mortality after Colectomy for Clostridium difficile
Kulaylat, A. S., Kassam, Z., Hollenbeak, C. S., & Stewart Sr, D. B. (2017). A Surgical Clostridium-Associated Risk of Death Score Predicts Mortality After Colectomy for Clostridium difficile. Diseases of the Colon & Rectum60(12), 1285-1290.

Fecal microbiota transplantation differentially influences the gut microbiota of Clostridium difficile infection and ileal pouch anal anastomosis patients
Piceno, Y. M., El-Nachef, N., Kassam, Z., Smith, M., Lynch, K., Zydek, M., ... & Lynch, S. (2017). Fecal Microbiota Transplantation Differentially Influences the Gut Microbiota of Clostridium Difficile Infection and Ileal Pouch Anal Anastomosis Patients. Gastroenterology152(5), S1006.

Fecal microbiota transplantation is safe and effective for the treatment of Clostridium difficile infection in solid organ transplant recipients
Piceno, Y. M., El-Nachef, N., Kassam, Z., Smith, M., Lynch, K., Zydek, M., ... & Lynch, S. (2017). Fecal Microbiota Transplantation Differentially Influences the Gut Microbiota of Clostridium Difficile Infection and Ileal Pouch Anal Anastomosis Patients. Gastroenterology152(5), S1006.

Pediatric access to fecal microbiota transplantation for recurrent Clostridium difficile Infection in the United States and the impact of stool banks: a geospatial analysis
Panchal, P., Budree, S., Tu, E., Kahn, S. A., Allegretti, J. R., Fischer, M., ... & Osman, M. (2017). Pediatric Access to Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection in the United States and the Impact of Stool Banks: A Geospatial Analysis. Gastroenterology152(5), S849-S850.

Faecal microbiota transplantation for Clostridium difficile infection: a multicentre study of non-responders
Razik, R., Osman, M., Lieberman, A., Allegretti, J. R., & Kassam, Z. (2017). Faecal microbiota transplantation for Clostridium difficile infection: a multicentre study of non-responders. Med J Aust; 207 (4): 159-160. 

2016

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Fischer, M., Kao, D., Kelly, C., Kuchipudi, A., Jafri, S. M., Blumenkehl, M., ... & Cook, G. (2016). Fecal microbiota transplantation is safe and efficacious for recurrent or refractory Clostridium difficile infection in patients with inflammatory bowel disease. Inflammatory bowel diseases22(10), 2402-2409.

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050-Patient Multicenter Cohort Osman, M., O'Brien, K., Stoltzner, Z., Ling, K., Koelsch, E., & Dubois, N. et al. (2016). Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050-Patient Multicenter Cohort. Open Forum Infectious Diseases3(suppl_1). doi:10.1093/ofid/ofw172.1668

2014

Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges Kassam, Z., Lee, C., & Hunt, R. (2014). Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics In Laboratory Medicine34(4), 787-798. doi:10.1016/j.cll.2014.08.007


FMT Safety & Access

2019

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications Allegretti, J., Mullish, B., Kelly, C., & Fischer, M. (2019). The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. The Lancet, 394(10196), 420-431. doi:10.1016/s0140-6736(19)31266-8

Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis? Allegretti, J., Kao, D., Phelps, E., Roach, B., Smith, J., & Ganapini, V. et al. (2019). Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?. Digestive Diseases And Sciences. doi:10.1007/s10620-018-5450-4

Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT) Allegretti, J.R., Kassam, Z., Fischer, M., Kelly, C., & Chan W.W. (2019). Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT). Journal Of Clinical Gastroenterology, 1. doi:10.1097/mcg.0000000000001194

Nuts and Bolts of Fecal Microbiota Transplantation Krajicek, E., Fischer, M., Allegretti, J., & Kelly, C. (2019). Nuts and Bolts of Fecal Microbiota Transplantation. Clinical Gastroenterology And Hepatology17(2), 345-352. doi:10.1016/j.cgh.2018.09.029

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis Shin, J., Chaplin, A., Hays, R., Kolling, G., Vance, S., & Guerrant, R. et al. (2019). Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis. Journal Of Clinical Medicine8(7), 1036. doi:10.3390/jcm8071036

2018

Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation? 
Allegretti, J. R., Kassam, Z., & Chan, W. W. (2018). Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?. Digestive diseases and sciences63(1), 193-197.

The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection
Allegretti, J. R., Kassam, Z., Osman, M., Budree, S., Fischer, M., & Kelly, C. R. (2018). The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointestinal endoscopy87(1), 18-29.

Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality. 
Barnes, D., Ng, K., Smits, S., Sonnenburg, J., Kassam, Z., & Park, K. T. (2018). Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality. Journal of pediatric gastroenterology and nutrition.

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
Brown, J. R. M., Flemer, B., Joyce, S. A., Zulquernain, A., Sheehan, D., Shanahan, F., & O’Toole, P. W. (2018). Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. BMC Gastroenterology, 18(1), 131.

Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection? Budree, S., Osman, M., Panchal, P., Shu, E., Carrellas, M., Kassam, Z., & Allegretti, J. (2018, November). 618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?. Open Forum Infectious Diseases (Vol. 5, No. suppl_1, pp. S225-S226). US: Oxford University Press.

Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital Duarte-Chavez, R., Wojda, T. R., Zanders, T. B., Geme, B., Fioravanti, G., & Stawicki, S. P. (2018). Early results of fecal microbial transplantation protocol implementation at a community-based university hospital. Journal of global infectious diseases, 10(2), 47.

Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future Panchal, P., Budree, S., Scheeler, A., Medina, G., Seng, M., Wong, W. F., & Eliot, R. (2018). Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future. Current Gastroenterology Reports, 20(4), 14.

Scaling Access to Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the United States: A Geospatial Time-Series Analysis from 2013 to 2017 Panchal, P., Elliott, R. J., Budree, S., Osman, M., Allegretti, J. R., Kelly, C. R., ... & Kassam, Z. (2018). 1010-Scaling Access to Fecal Microbiota Transplantation for Recurrent Clostridium Difficle Infection in the United States: A Geospatial Time-Series Analysis from 2013 to 2017. Gastroenterology, 154(6), S-190.

Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis
Panchal, P., Kahn, S., Zellmer, C., Kassam, Z., Osman, M., Allegretti, J., ... & NASPGHAN FMT Special Interest Group. (2018, November). 533. Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis. Open Forum Infectious Diseases (Vol. 5, No. suppl_1, pp. S197-S197). US: Oxford University Press.

Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation
Smillie, C. S., Sauk, J., Gevers, D., Friedman, J., Sung, J., Youngster, I., ... & Allegretti, J. R. (2018). Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell host & microbe23(2), 229-240.

2017

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present and Future
Allegretti, J., Eysenbach, L. M., El-Nachef, N., Fischer, M., Kelly, C., & Kassam, Z. (2017). The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future. Inflammatory bowel diseases23(10), 1710-1717.

Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment Failure
Allegretti, J. R., Kao, D., Sitko, J., Fischer, M., & Kassam, Z. (2017). Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment Failure. Clinical Infectious Diseases66(1), 134-135.

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures. 
Allegretti, J. R., Phelps, E., Allegretti, A., Xu, H., Fischer, M., & Kassam, Z. (2017). Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association.

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., ... & Williams, R. (2017). Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology.

Fecal microbiota transplant using a precision medicine approach is safe, associated with lower hospitalization risk and improved cognitive function in recurrent hepatic encephalopathy
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E., Liu, E. J., Kheradman, R., ... & Alm, E. (2017). Fecal microbiota transplant using a precision medicine approach is safe, Associated with lower hospitalization risk and improved cognitive function in recurrent hepatic encephalopathy. Gastroenterology152(5), S906.

Donor stool processing time: the effect on the intestinal microbiome and clinical outcomes of fecal microbiota transplantation in Clostridium difficile Infection
Budree, S., Elliott, R. J., Rao, S., Njenga, M., Ladha, A., Allegretti, J. R., ... & Kassam, Z. (2017). Donor Stool Processing Time: The Effect on the Intestinal Microbiome and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S1006.

The association of donor stool consistency by Bristol stool scale on microbial profile and clinical outcomes of fecal microbiota transplantation in Clostridium difficile infection
Budree, S., Rao, S., Allegretti, J. R., Fischer, M., Kelly, C. R., Smith, M., ... & Kassam, Z. (2017). The Association of Donor Stool Consistency by Bristol Stool Scale on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630.

The association of stool donor diet on microbial profile and clinical outcomes of fecal microbiota transplantation in clostridium difficile infection
Budree, S., Tu, E., Leith, T., Allegretti, J. R., Rao, S., Day, R., ... & Osman, M. (2017). The Association of Stool Donor Diet on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630-S631.

Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors
Budree, S., Wong, W. F., Tu, E., Rao, S., Allegretti, J. R., Fischer, M., ... & Kassam, Z. (2017). Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors. Gastroenterology152(5), S349.

Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations
Chu, N. D., Smith, M. B., Perrotta, A. R., Kassam, Z., & Alm, E. J. (2017). Profiling living bacteria informs preparation of fecal microbiota transplantations. PloS one12(1), e0170922.

The role of fecal microbiota transplantation in ulcerative colitis and Crohn’s disease: results from a parallel inflammatory bowel disease cohort study
El-Nachef, N., Piceno, Y. M., Kassam, Z., Ablaza, A. J., Zydek, M., Lynch, K., ... & Lynch, S. (2017). The Role of Fecal Microbiota Transplantation in Ulcerative Colitis and Crohn's Disease: Results from a Parallel Inflammatory Bowel Disease Cohort Study. Gastroenterology152(5), S1008.

Fecal microbiota transplantation is safe and effective in chronic pouchitis patients
El-Nachef, N., Piceno, Y. M., Kassam, Z., Zydek, M., Ablaza, A. J., Leith, T., ... & Lynch, S. (2017). Fecal Microbiota Transplantation is Safe and Effective in Chronic Pouchitis Patients. Gastroenterology152(5), S1009.

Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease
Fischer, M., Bittar, M., Papa, E., Kassam, Z., & Smith, M. (2017). Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut microbes8(3), 205-207.

Should we recommend anti-Clostridium difficile antibiotic or probiotic prophylaxis? Risk of Clostridium difficile infection with systemic antimicrobial therapy following successful fecal microbiota transplant
Fischer, M., Kao, D. H., Phelps, E. L., Smith, J. D., Roach, B., Kassam, Z., ... & Allegretti, J. R. (2017). Should we Recommend Anti-Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant. Gastroenterology152(5), S1005.

Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection
Fischer, M., Kao, D., Kassam, Z., Smith, J., Louie, T., Sipe, B., ... & Allegretti, J. R. (2017). Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for C. difficile Infection. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association.

Fecal microbiota transplantation is safe and effective for the treatment of Clostridium difficile infection in solid organ transplant recipients
Fischer, M., Khan, M., Phelps, E. L., Safdar, N., Misch, E. A., Kaur, N., ... & Xu, H. (2017). Fecal Microbiota Transplantation is Safe and Effective for the Treatment of Clostridium Difficile Infection in Solid Organ Transplant Recipients. Gastroenterology152(5), S1005.

Fecal microbiota transplant in severe and severe complicated Clostridium difficile: a promising treatment approach
Fischer, M., Sipe, B., Cheng, Y. W., Phelps, E., Rogers, N., Sagi, S., ... & Kassam, Z. (2017). Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach. Gut microbes8(3), 289-302.

Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis
Jacob, V., Crawford, C., Cohen-Mekelburg, S., Viladomiu, M., Putzel, G. G., Schneider, Y., ... & Ajami, N. J. (2017). Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis. Inflammatory bowel diseases23(6), 903-911.

Prevalence of early antibiotic use post-fecal microbiota transplantation and corresponding risk of FMT failure.Allegretti, J. R., Kao, D. H., Sitko, J., Fischer, M., & Kassam, Z. (2017). Prevalence of Early Antibiotic Use Post-Fecal Microbiotatransplantation and Corresponding Risk of FMT Failure. Gastroenterology152(5), S342-S343.

Systematic Review and Meta-Analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
Narula, N., Kassam, Z., Yuan, Y., Colombel, J. F., Ponsioen, C., Reinisch, W., & Moayyedi, P. (2017). Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflammatory bowel diseases23(10), 1702-1709.

Pediatric access to fecal microbiota transplantation for recurrent Clostridium difficile Infection in the United States and the impact of stool banks: a geospatial analysis
Panchal, P., Budree, S., Tu, E., Kahn, S. A., Allegretti, J. R., Fischer, M., ... & Osman, M. (2017). Pediatric Access to Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection in the United States and the Impact of Stool Banks: A Geospatial Analysis. Gastroenterology152(5), S849-S850.

Fecal microbiota transplantation differentially influences the gut microbiota of Clostridium difficile infection and ileal pouch anal anastomosis patients
Piceno, Y. M., El-Nachef, N., Kassam, Z., Smith, M., Lynch, K., Zydek, M., ... & Lynch, S. (2017). Fecal Microbiota Transplantation Differentially Influences the Gut Microbiota of Clostridium Difficile Infection and Ileal Pouch Anal Anastomosis Patients. Gastroenterology152(5), S1006.

The Risk of Inflammatory Bowel Disease Flares after Fecal Microbiota Transplantation: Systematic Review and Meta-Analysis
Qazi, T., Amaratunga, T., Barnes, E. L., Fischer, M., Kassam, Z., & Allegretti, J. R. (2017). The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut microbes8(6), 574-588

Faecal microbiota transplantation for Clostridium difficile infection: a multicentre study of non-responders
Razik, R., Osman, M., Lieberman, A., Allegretti, J. R., & Kassam, Z. (2017). Faecal microbiota transplantation for Clostridium difficile infection: a multicentre study of non-responders. N Engl J Med368, 407-415.

Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals
Vujkovic-Cvijin, I., Rutishauser, R. L., Pao, M., Hunt, P. W., Lynch, S. V., McCune, J. M., & Somsouk, M. (2017). Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut microbes8(5), 440-450.

2016

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Fischer, M., Kao, D., Kelly, C., Kuchipudi, A., Jafri, S. M., Blumenkehl, M., ... & Cook, G. (2016). Fecal microbiota transplantation is safe and efficacious for recurrent or refractory Clostridium difficile infection in patients with inflammatory bowel disease. Inflammatory bowel diseases22(10), 2402-2409.

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050-Patient Multicenter Cohort Osman, M., O'Brien, K., Stoltzner, Z., Ling, K., Koelsch, E., & Dubois, N. et al. (2016). Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050-Patient Multicenter Cohort. Open Forum Infectious Diseases3(suppl_1). doi:10.1093/ofid/ofw172.1668

2015

Seeking safe stool: Canada needs a universal donor model Edelstein, C., Daw, J., & Kassam, Z. (2015). Seeking safe stool: Canada needs a universal donor model. Canadian Medical Association Journal188(17-18), E431-E432. doi:10.1503/cmaj.150672

Prospective Assessment of Donor Eligibility for Fecal Microbiota Transplantation at a Public Stool Bank: Results From the Evaluation of 1,387 Candidate Donors Dubois, N., Ling, K., Osman, M., Burns, L., Mendolia, G., Blackler, D., Burgess, J., Edelstein, C., Noh, A., Vo, E., Alm E., Smith, M., and Kassam, Z. (2015). Prospective Assessment of Donor Eligibility for Fecal Microbiota Transplantation at a Public Stool Bank: Results From the Evaluation of 1,387 Candidate Donors. Idsa. Retrieved from https://idsa.confex.com/idsa/2015/webprogram/Paper52979.html

Ensuring the safe and effective FDA regulation of fecal microbiota transplantation Sachs, R., & Edelstein, C. (2015). Ensuring the safe and effective FDA regulation of fecal microbiota transplantation. Journal of Law and the Biosciences. 2. 10.1093/jlb/lsv032.

2014

Policy: How to regulate faecal transplants Smith, M., Kelly, C., & Alm, E. (2014). Policy: How to regulate faecal transplants. Nature506(7488), 290-291. doi:10.1038/506290a

OpenBiome remains open to serve the medical community Smith, M., Kassam, Z., Edelstein, C., Burgess, J., Alm, E., & Ratner, M. et al. (2014). OpenBiome remains open to serve the medical communityNature Biotechnology.


Stool Donors

2018

Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality. 
Barnes, D., Ng, K., Smits, S., Sonnenburg, J., Kassam, Z., & Park, K. T. (2018). Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality. Journal of pediatric gastroenterology and nutrition.

Does the Donor Matter? Microbiome Sequencing to Evaluate Lower Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Osman, M., Abend, A., Panchal, P., Kassam, Z., & Budree, S. (2018). 88-Does the Donor Matter? Microbiome Sequencing to Evaluate Lower Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection. Gastroenterology, 154(6), S-25.

2017

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., ... & Williams, R. (2017). Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology.

Donor stool processing time: the effect on the intestinal microbiome and clinical outcomes of fecal microbiota transplantation in Clostridium difficile Infection
Budree, S., Elliott, R. J., Rao, S., Njenga, M., Ladha, A., Allegretti, J. R., ... & Kassam, Z. (2017). Donor Stool Processing Time: The Effect on the Intestinal Microbiome and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S1006.

The association of donor stool consistency by Bristol stool scale on microbial profile and clinical outcomes of fecal microbiota transplantation in Clostridium difficile infection
Budree, S., Rao, S., Allegretti, J. R., Fischer, M., Kelly, C. R., Smith, M., ... & Kassam, Z. (2017). The Association of Donor Stool Consistency by Bristol Stool Scale on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630.

The association of stool donor diet on microbial profile and clinical outcomes of fecal microbiota transplantation in clostridium difficile infection
Budree, S., Tu, E., Leith, T., Allegretti, J. R., Rao, S., Day, R., ... & Osman, M. (2017). The Association of Stool Donor Diet on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology152(5), S630-S631.

Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors
Budree, S., Wong, W. F., Tu, E., Rao, S., Allegretti, J. R., Fischer, M., ... & Kassam, Z. (2017). Do Specific Bacteria Drive Clinical Cure in Fecal Microbiota Transplantation for Clostridium Difficile Infection?: Clinical, Microbial and Metabolomic Characterization of Universal FMT Donors. Gastroenterology152(5), S349.

Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease
Fischer, M., Bittar, M., Papa, E., Kassam, Z., & Smith, M. (2017). Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut microbes8(3), 205-207.

Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection
Fischer, M., Kao, D., Kassam, Z., Smith, J., Louie, T., Sipe, B., ... & Allegretti, J. R. (2017). Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for C. difficile Infection. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association.

Does fecal microbiota transplantation from an obese donor lead to weight gain? A case series of 70 recipients
Fischer, M., Sipe, B., Torbeck, M., Xu, H., Kassam, Z., & Allegretti, J. R. (2017). Does fecal microbiota transplantation from an obese donor lead to weight gain? A case series of 70 recipients. Gastroenterology152(5), S1004


Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's, & others)

2019

Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Gogokhia, L., Buhrke, K., Bell, R., Hoffman, B., Brown, D., & Hanke-Gogokhia, C. et al. (2019). Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host & Microbe25(2), 285-299.e8. doi:10.1016/j.chom.2019.01.008

Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile Gutin, L., Piceno, Y., Fadrosh, D., Lynch, K., Zydek, M., & Kassam, Z. et al. (2019). Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile. United European Gastroenterology Journal, 7(6), 807-814. doi:10.1177/2050640619845986

Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment Herfarth, H., Barnes, E. L., Long, M. D., Isaacs, K. L., Leith, T., Silverstein, M., … Kassam, Z. (2019). Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment. Inflammatory Intestinal Diseases, 1–6. doi:10.1159/000497042

Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study Selvig, D., Piceno, Y., Terdiman, J., Zydek, M., Umetsu, S., & Balitzer, D. et al. (2019). Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. Digestive Diseases And Sciences. doi:10.1007/s10620-019-05715-2

2018

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease
Ibraheim, H., Giacomini, C., Kassam, Z., Dazzi, F., & Powell, N. (2018). Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease. Expert review of Gastroenterology & Hepatology12(2), 141-153.

2017

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present and Future
Allegretti, J., Eysenbach, L. M., El-Nachef, N., Fischer, M., Kelly, C., & Kassam, Z. (2017). The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future. Inflammatory bowel diseases23(10), 1710-1717.

Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases Borren, N. Z., Conway, G., Garber, J. J., Khalili, H., Budree, S., Mallick, H., ... & Ananthakrishnan, A. N. (2017). Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. Journal of Crohn's and Colitis, 12(5), 525-531.

Does Rifaximin prior to fecal microbiota transplantation improve clinical outcomes compared to microbiome restoration alone in ulcerative colitis? A cohort study evaluating the impact of non-absorbable antibiotic pretreatment
El-Nachef, N., Kassam, Z., Piceno, Y. M., Ablaza, A. J., Zydek, M., Elliott, R. J., ... & Somsouk, M. (2017). Does Rifaximin Prior to Fecal Microbiota Transplantation Improve Clinical Outcomes Compared to Microbiome Restoration Alone in Ulcerative Colitis? a Cohort Study Evaluating the Impact of Non-Absorbable Antibiotic Pretreatment. Gastroenterology152(5), S1008-S1009.

The role of fecal microbiota transplantation in ulcerative colitis and Crohn’s disease: results from a parallel inflammatory bowel disease cohort study
El-Nachef, N., Piceno, Y. M., Kassam, Z., Ablaza, A. J., Zydek, M., Lynch, K., ... & Lynch, S. (2017). The Role of Fecal Microbiota Transplantation in Ulcerative Colitis and Crohn's Disease: Results from a Parallel Inflammatory Bowel Disease Cohort Study. Gastroenterology152(5), S1008.

Fecal microbiota transplantation is safe and effective in chronic pouchitis patients
El-Nachef, N., Piceno, Y. M., Kassam, Z., Zydek, M., Ablaza, A. J., Leith, T., ... & Lynch, S. (2017). Fecal Microbiota Transplantation is Safe and Effective in Chronic Pouchitis Patients. Gastroenterology152(5), S1009.

Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease
Fischer, M., Bittar, M., Papa, E., Kassam, Z., & Smith, M. (2017). Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut microbes8(3), 205-207.

Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis
Jacob, V., Crawford, C., Cohen-Mekelburg, S., Viladomiu, M., Putzel, G. G., Schneider, Y., ... & Ajami, N. J. (2017). Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis. Inflammatory bowel diseases23(6), 903-911.

A Surgical Clostridium-associated Risk of Death Score Predicts Mortality after Colectomy for Clostridium difficile
Kulaylat, A. S., Kassam, Z., Hollenbeak, C. S., & Stewart Sr, D. B. (2017). A Surgical Clostridium-Associated Risk of Death Score Predicts Mortality After Colectomy for Clostridium difficile. Diseases of the Colon & Rectum60(12), 1285-1290.

Systematic Review and Meta-Analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
Narula, N., Kassam, Z., Yuan, Y., Colombel, J. F., Ponsioen, C., Reinisch, W., & Moayyedi, P. (2017). Systematic review and meta-analysis: Fecal microbiota transplantation for treatment of active ulcerative colitis. Inflammatory bowel diseases23(10), 1702-1709.

Fecal microbiota transplantation differentially influences the gut microbiota of Clostridium difficile infection and ileal pouch anal anastomosis patients
Piceno, Y. M., El-Nachef, N., Kassam, Z., Smith, M., Lynch, K., Zydek, M., ... & Lynch, S. (2017). Fecal Microbiota Transplantation Differentially Influences the Gut Microbiota of Clostridium Difficile Infection and Ileal Pouch Anal Anastomosis Patients. Gastroenterology152(5), S1006.

The Risk of Inflammatory Bowel Disease Flares after Fecal Microbiota Transplantation: Systematic Review and Meta-Analysis
Qazi, T., Amaratunga, T., Barnes, E. L., Fischer, M., Kassam, Z., & Allegretti, J. R. (2017). The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut microbes8(6), 574-588.

2016

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Fischer, M., Kao, D., Kelly, C., Kuchipudi, A., Jafri, S. M., Blumenkehl, M., ... & Cook, G. (2016). Fecal microbiota transplantation is safe and efficacious for recurrent or refractory Clostridium difficile infection in patients with inflammatory bowel disease. Inflammatory bowel diseases22(10), 2402-2409.


Liver Disease

2019

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial      Allegretti, J., Kassam, Z., Carrellas, M., Mullish, B., Marchesi, J., & Pechlivanis, A. et al. (2019). Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis. The American Journal Of Gastroenterology, 1. doi:10.14309/ajg.0000000000000115 

Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis Bajaj, JS., Fagan, A., Gavis, EA., Kassam, Z., Sikaroodi, M., Gillevet, P. (2019). Long term outcomes after Fecal Microbiota Transplant in Cirrhosis. Gastroenterology, doi: https://doi.org/10.1053/j.gastro.2019.01.033

2018

Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant Bajaj, J. S., Kakiyama, G., Savage, T., Takei, H, Kassam, Z. A., Fagan, A., … & Gillevet, P. M. (2018). Antibiotic‐Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant. Hepatology, 68: 1549-1558.

2017

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., ... & Williams, R. (2017). Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology.

Fecal microbiota transplant using a precision medicine approach is safe, associated with lower hospitalization risk and improved cognitive function in recurrent hepatic encephalopathy
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E., Liu, E. J., Kheradman, R., ... & Alm, E. (2017). Fecal microbiota transplant using a precision medicine approach is safe, Associated with lower hospitalization risk and improved cognitive function in recurrent hepatic encephalopathy. Gastroenterology152(5), S906.

The Gut Microbiome in Autoimmune Hepatitis Links to Disease Progression and is Significantly Different from Lupus and Healthy Controls
Kumar, V., Vieira, S. M., Ruff, W., Dehner, C., Kassam, Z., Boyer, J. L., ... & Kriegel, M. (2017, October). The Gut Microbiome in Autoimmune Hepatitis Links to Disease Progression and is Significantly Different from Lupus and Healthy Controls. HEPATOLOGY (Vol. 66, pp. 189A-189A).


Obesity

2019

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients Allegretti, J., Kassam, Z., Mullish, B., Chiang, A., Carrellas, M., & Hurtado, J. et al. (2019). Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients. Clinical Gastroenterology And Hepatology. doi:10.1016/j.cgh.2019.07.006

2017

Does fecal microbiota transplantation from an obese donor lead to weight gain? A case series of 70 recipients
Fischer, M., Sipe, B., Torbeck, M., Xu, H., Kassam, Z., & Allegretti, J. R. (2017). Does fecal microbiota transplantation from an obese donor lead to weight gain? A case series of 70 recipients. Gastroenterology152(5), S1004.


AND MORE

2019

Framework for rational donor selection in fecal microbiota transplant clinical trials Duvallet, C., Zellmer, C., Panchal, P., Budree, S., Osman, M., & Alm, E. (2019). Framework for rational donor selection in fecal microbiota transplant clinical trials. doi:10.1101/19000307

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial Aroniadis, O., Brandt, L., Oneto, C., Feuerstadt, P., Sherman, A., & Wolkoff, A. et al. (2019). Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. The Lancet Gastroenterology & Hepatology. doi:10.1016/s2468-1253(19)30198-0

Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy Koya, S., Yurgelevic, S., Brusatori, M., Huang, C., Diebel, L., & Auner, G. (2019). Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy. Journal Of Surgical Research, 244, 111-116. doi:10.1016/j.jss.2019.06.039

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study Santiago, M., Eysenbach, L., Allegretti, J., Aroniadis, O., J. Brandt, L., & Fischer, M. et al. (2019). Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. AIMS Microbiology, 5(1), 1-18. doi:10.3934/microbiol.2019.1.1

2018

Intestinal Microbial and Metabolic Alterations Following Successful Fecal Microbiota Transplant for D-Lactic Acidosis Bulik-Sullivan, E. C., Roy, S., Elliott, R. J., Kassam, Z., Lichtman, S. N., Carroll, I. M., & Gulati, A. S. (2018). Intestinal microbial and metabolic alterations following successful fecal microbiota transplant for D-lactic acidosis. Journal of Pediatric Gastroenterology and Nutrition, 67(4), 483-487.

HIV-exposure, early life feeding practices and delivery mode impacts on faecal bacterial profiles in a South African birth cohort Claassen-Weitz, S., Gardner-Lubbe, S., Nicol, P., Botha, G., Mounaud, S., Shankar, J., ... & Nicol, M. P. (2018). HIV-exposure, early life feeding practices and delivery mode impacts on faecal bacterial profiles in a South African birth cohort. Scientific Reports, 8(1), 5078.

Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort Gurry, T., HST Microbiome Consortium*, Gibbons, S. M., Nguyen, L., Kearney, S. M., Ananthakrishnan, A., Jiang, X., Duvallet, C., Kassam, Z., … Alm, E. J. (2018). Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort. Scientific Reports, 8(1), 12699. doi:10.1038/s41598-018-30783-1

Fecal Microbiota Transplantation Improves Gastrointestinal Graft-Versus-Host Disease and Restores the Microbiome: A Pediatric Experience Wong, W. F., Budree, S., Osman, M., Panchal, P., Kassam, Z., Corkins, M. R., ... & Maron, G. M. (2018). Tu1882-Fecal Microbiota Transplantation Improves Gastrointestinal Graft-Versus-Host Disease and Restores the Microbiome: A Pediatric Experience. Gastroenterology, 154(6), S-1046.